You are here

  • Home
  • Archive
  • Volume 12, Issue Suppl 1
  • P02.07 Trial in progress: anti-PD1, capecitabine, and oxaliplatin for the first-line treatment of dMMR esophagogastric cancer (AuspiCiOus-dMMR): a proof-of-principle study (AuspiCiOus)

Article metrics

Article menu

Download PDFPDF

Poster Presentations
02. Tumor microenvironment and microbiome in immunotherapy
P02.07 Trial in progress: anti-PD1, capecitabine, and oxaliplatin for the first-line treatment of dMMR esophagogastric cancer (AuspiCiOus-dMMR): a proof-of-principle study (AuspiCiOus)

 

Online download statistics by month:

Online download statistics by month: March 2024 to June 2025

AbstractFullPdf
Mar 202464017
Apr 20244204
May 20241600
Jun 20242503
Jul 20242402
Aug 2024602
Sep 20241201
Oct 20241207
Nov 20242005
Dec 20241608
Jan 20251306
Feb 202510023
Mar 20250015
Apr 2025007
May 2025009
Jun 2025003
Total2600112